abstract |
The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula I: n n wherein W, X, Y, Z, R 1 , R 2 , R 5 , and R 8 are as described herein. |